A randomized controlled trial investigating tailored treatment with infliximab for active luminal crohn's disease

To investigate whether sustained trough levels of IFX can be achieved using IFX trough level measurements and adjustment of dosing based upon these levels by means of two different standardized algorythms in comparison with �standard of care� IFX treatment and its effects on clinical and endoscopic outcomes